# The role of Smyd4 in regulating cardioprogenitor specification.

> **NIH NIH P01** · INDIANA UNIVERSITY INDIANAPOLIS · 2024 · $431,524

## Abstract

PROJECT ABSTRACT
Members of SET and MYND domain-containing protein (SMYDs) family are unique lysine methyltransferases
that play important roles during embryogenesis via the regulation of histone H3 lysine residues that impart both
transcriptional activation and repression functions. SMYD1 is known for its function in regulating cardiomyocyte
differentiation and maturation. Our previous study on the role of SMYD4 in Zebrafish suggesting that smyd4 is
critical to early embryonic development and cardiogenesis. Our recent transcriptomic analysis of smyd4-ablated
zebrafish blastula and early gastrula embryos has revealed significant changes in gene regulatory networks
involved in the specification of mesendoderm and the differentiation of cardiac progenitor cells (CPCs). These
data suggest that smyd4 may be involved in cardiogenic-lineage specification and differentiation prior to overt
heart formation. Importantly, we demonstrate that de novo SMYD4 genetic variants are associated with
congenital heart defects (CHDs). To establish the mechanistic basis for the genetic association of SMYD4 to
CHDs, we have analyzed the temporal expression pattern of SMYD4 within human embryonic stem cells
(hESCs) and their induced differentiation into cardiomyocytes. We find that SMYD4 is expressed throughout the
differentiation process from hESCs to cardiomyocytes. Genetic ablation of SMYD4 in hESCs (hESC-SMYD4KO)
resulted in dramatically compromised mesodermal specification and CPC differentiation, thus phenocopying the
early developmental and cardiac defects observed in smyd4 mutant zebrafish. Additional transcriptomic analysis
further supports that induced cardiomyogenic differentiation of hESCs-SMYD4KO is severely altered, where
hESCs-SMYD4KO adopt a more neuroectodermal lineage fate. Quantitative mass spectrometry analysis reveals
that BACH1, a critical transcriptional regulator of stem cell pluripotency and lineage specification, as a strong
SMYD4 binding partner. Based on these preliminary data, we hypothesize that SMYD4 functions as a critical
epigenetic regulator for mesendoderm specification and cardiac development via its interaction with BACH1. In
this project, we propose 3 specific aims to define the biological and molecular function of SMYD4 in
mesendoderm specification and cardiac development. Aim 1 tests the hypothesis that SMYD4 is critical to
mesoderm specification and cardiogenic differentiation by performing genetic rescue experiment and a series of
genome-wide integrated analyses, including the single-cell RNA-seq and DNA occupancy analyses, to define
the potentially altered histone epigenetic landscape during cardiomyocyte differentiation in mutant hESCs. Aim
2 tests the hypothesis that BACH1-SMYD4 complexes are critical to the epigenetic regulation of mesoderm
specification and cardiogenic differentiation by determining the protein-protein interaction domains and BACH1-
SMYD4 specific targeted genes using CUT&RUN analysis. Aim 3 tests the hypot...

## Key facts

- **NIH application ID:** 10755292
- **Project number:** 5P01HL134599-07
- **Recipient organization:** INDIANA UNIVERSITY INDIANAPOLIS
- **Principal Investigator:** WEINIAN SHOU
- **Activity code:** P01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $431,524
- **Award type:** 5
- **Project period:** 2017-02-15 → 2028-01-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10755292

## Citation

> US National Institutes of Health, RePORTER application 10755292, The role of Smyd4 in regulating cardioprogenitor specification. (5P01HL134599-07). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10755292. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*